Torisel

• 

Real world use of targeted therapies in war veterans with kidney cancer

By Sharon Kell|2019-11-19T14:40:20+00:0019 Nov 2019|Drug treatments|

A retrospective study of the use of targeted therapies for [...]

Read More

Comments Off on Real world use of targeted therapies in war veterans with kidney cancer

• 

Current role of mTOR inhibitors in metastatic kidney cancer

By Sharon Kell|2019-01-04T09:01:44+00:004 Jan 2019|Drug treatments|

The following video interview with Dr Eric Jonasch, from the [...]

Read More

Comments Off on Current role of mTOR inhibitors in metastatic kidney cancer

• 

Combination bevacizumab plus temsirolimus for second-line treatment of metastatic kidney cancer

By Sharon Kell|2018-11-15T14:42:24+00:0015 Nov 2018|Drug treatments|

A recent phase 2 study evaluated the combination of bevacizumab [...]

Read More

Comments Off on Combination bevacizumab plus temsirolimus for second-line treatment of metastatic kidney cancer

Potential biomarkers may predict response to TKIs in metastatic kidney cancer

By Sharon Kell|2018-08-17T16:00:41+00:0017 Aug 2018|Drug treatments|

A recent study published in Clinical Cancer Research and conducted in [...]

Read More

Comments Off on Potential biomarkers may predict response to TKIs in metastatic kidney cancer

Axitinib for metastatic non-clear cell renal cell carcinoma

By Sharon Kell|2018-06-20T15:37:41+00:0020 Jun 2018|Drug treatments|

Results from a phase 2 clinical trial of axitinib (Inlyta) [...]

Read More

Comments Off on Axitinib for metastatic non-clear cell renal cell carcinoma